Literature DB >> 31344986

Sox2 dosage: A critical determinant in the functions of Sox2 in both normal and tumor cells.

Ethan P Metz1, Angie Rizzino1.   

Abstract

The stem cell transcription factor Sox2 is widely recognized for its many roles during normal development and cancer. Over the last several years, it has become increasingly evident that Sox2 dosage plays critical roles in both normal and malignant cells. The work described in this review indicates that the dosage of Sox2 influences cell fate decisions made during normal mammalian development, as well as cell fate decisions in cancer, including those that influence the tumor cell of origin and progression of the cancer. Equally important, Sox2 dosage is a key determinant in the proliferation of both normal cells and tumor cells, where proliferation is restricted in Sox2high cells. Collectively, the studies reviewed here indicate that tumor cells utilize the fundamental effects of Sox2 dosage to suit their own needs. Finally, we speculate that elevated expression of Sox2 helps establish and maintain tumor dormancy in Sox2-positive cancers.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  Sox2; cancer; development; dormancy; quiescence

Mesh:

Substances:

Year:  2019        PMID: 31344986      PMCID: PMC6662612          DOI: 10.1002/jcp.28610

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  48 in total

1.  The transcription factor SOX9 regulates cell cycle and differentiation genes in chondrocytic CFK2 cells.

Authors:  D K Panda; D Miao; V Lefebvre; G N Hendy; D Goltzman
Journal:  J Biol Chem       Date:  2001-08-20       Impact factor: 5.157

2.  Bilateral anophthalmia and brain malformations caused by a 20-bp deletion in the SOX2 gene.

Authors:  J C Zenteno; G Gascon-Guzman; J L Tovilla-Canales
Journal:  Clin Genet       Date:  2005-12       Impact factor: 4.438

3.  Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells.

Authors:  H Niwa; J Miyazaki; A G Smith
Journal:  Nat Genet       Date:  2000-04       Impact factor: 38.330

4.  SOX2 mutation causes anophthalmia, hearing loss, and brain anomalies.

Authors:  Stephanie A Hagstrom; Gayle J T Pauer; Janet Reid; Ellen Simpson; Sue Crowe; Irene H Maumenee; Elias I Traboulsi
Journal:  Am J Med Genet A       Date:  2005-10-01       Impact factor: 2.802

5.  Reciprocal transcriptional regulation of Pou5f1 and Sox2 via the Oct4/Sox2 complex in embryonic stem cells.

Authors:  Joon-Lin Chew; Yuin-Han Loh; Wensheng Zhang; Xi Chen; Wai-Leong Tam; Leng-Siew Yeap; Pin Li; Yen-Sin Ang; Bing Lim; Paul Robson; Huck-Hui Ng
Journal:  Mol Cell Biol       Date:  2005-07       Impact factor: 4.272

Review 6.  Developmental eye disorders.

Authors:  David R Fitzpatrick; Veronica van Heyningen
Journal:  Curr Opin Genet Dev       Date:  2005-06       Impact factor: 5.578

7.  SOX2 anophthalmia syndrome.

Authors:  Nicola K Ragge; Birgit Lorenz; Adele Schneider; Kate Bushby; Luisa de Sanctis; Ugo de Sanctis; Alison Salt; J Richard O Collin; Anthony J Vivian; Samantha L Free; Pamela Thompson; Kathleen A Williamson; Sanjay M Sisodiya; Veronica van Heyningen; David R Fitzpatrick
Journal:  Am J Med Genet A       Date:  2005-05-15       Impact factor: 2.802

8.  Mutations in SOX2 cause anophthalmia.

Authors:  Judy Fantes; Nicola K Ragge; Sally-Ann Lynch; Niolette I McGill; J Richard O Collin; Patricia N Howard-Peebles; Caroline Hayward; Anthony J Vivian; Kathy Williamson; Veronica van Heyningen; David R FitzPatrick
Journal:  Nat Genet       Date:  2003-03-03       Impact factor: 38.330

9.  Role of SOX2 mutations in human hippocampal malformations and epilepsy.

Authors:  Sanjay M Sisodiya; Nicola K Ragge; Gianpiero L Cavalleri; Ann Hever; Birgit Lorenz; Adele Schneider; Kathleen A Williamson; John M Stevens; Samantha L Free; Pamela J Thompson; Veronica van Heyningen; David R Fitzpatrick
Journal:  Epilepsia       Date:  2006-03       Impact factor: 5.864

10.  Multipotent cell lineages in early mouse development depend on SOX2 function.

Authors:  Ariel A Avilion; Silvia K Nicolis; Larysa H Pevny; Lidia Perez; Nigel Vivian; Robin Lovell-Badge
Journal:  Genes Dev       Date:  2003-01-01       Impact factor: 11.361

View more
  9 in total

1.  Elevating SOX2 in prostate tumor cells upregulates expression of neuroendocrine genes, but does not reduce the inhibitory effects of enzalutamide.

Authors:  Ethan P Metz; Phillip J Wilder; Jixin Dong; Kaustubh Datta; Angie Rizzino
Journal:  J Cell Physiol       Date:  2019-10-06       Impact factor: 6.384

2.  Elevating SOX2 Downregulates MYC through a SOX2:MYC Signaling Axis and Induces a Slowly Cycling Proliferative State in Human Tumor Cells.

Authors:  Ethan P Metz; Phillip J Wilder; Tessa M Popay; Jing Wang; Qi Liu; Achyuth Kalluchi; M Jordan Rowley; William P Tansey; Angie Rizzino
Journal:  Cancers (Basel)       Date:  2022-04-12       Impact factor: 6.639

3.  O-GlcNAcylation of Sox2 at threonine 258 regulates the self-renewal and early cell fate of embryonic stem cells.

Authors:  Dong Keon Kim; Jang-Seok Lee; Eun Young Lee; Hansol Jang; Suji Han; Hee Yeon Kim; In-Young Hwang; Ji-Woong Choi; Hyun Mu Shin; Hye Jin You; Hong-Duk Youn; Hyonchol Jang
Journal:  Exp Mol Med       Date:  2021-11-24       Impact factor: 8.718

Review 4.  The current paradigm and challenges ahead for the dormancy of disseminated tumor cells.

Authors:  Emma Risson; Ana Rita Nobre; Veronique Maguer-Satta; Julio A Aguirre-Ghiso
Journal:  Nat Cancer       Date:  2020-07-06

5.  Blood-Based SOX2-Promoter Methylation in Relation to Exercise and PM2.5 Exposure among Taiwanese Adults.

Authors:  Chun-Lang Su; Disline Manli Tantoh; Ying-Hsiang Chou; Lee Wang; Chien-Chang Ho; Pei-Hsin Chen; Kuan-Jung Lee; Oswald Ndi Nfor; Shu-Yi Hsu; Wen-Miin Liang; Yung-Po Liaw
Journal:  Cancers (Basel)       Date:  2020-02-21       Impact factor: 6.639

6.  Tumor quiescence: elevating SOX2 in diverse tumor cell types downregulates a broad spectrum of the cell cycle machinery and inhibits tumor growth.

Authors:  Ethan P Metz; Erin L Wuebben; Phillip J Wilder; Jesse L Cox; Kaustubh Datta; Donald Coulter; Angie Rizzino
Journal:  BMC Cancer       Date:  2020-10-01       Impact factor: 4.430

7.  Sox2 is necessary for androgen ablation-induced neuroendocrine differentiation from Pten null Sca-1+ prostate luminal cells.

Authors:  Oh-Joon Kwon; Li Zhang; Deyong Jia; Li Xin
Journal:  Oncogene       Date:  2020-10-27       Impact factor: 9.867

8.  Distinct mechanisms control genome recognition by p53 at its target genes linked to different cell fates.

Authors:  Marina Farkas; Hideharu Hashimoto; Yingtao Bi; Ramana V Davuluri; Lois Resnick-Silverman; James J Manfredi; Erik W Debler; Steven B McMahon
Journal:  Nat Commun       Date:  2021-01-20       Impact factor: 17.694

Review 9.  Subgroup-Specific Diagnostic, Prognostic, and Predictive Markers Influencing Pediatric Medulloblastoma Treatment.

Authors:  Sutapa Ray; Nagendra K Chaturvedi; Kishor K Bhakat; Angie Rizzino; Sidharth Mahapatra
Journal:  Diagnostics (Basel)       Date:  2021-12-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.